116 related articles for article (PubMed ID: 17220542)
1. Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures.
Domin H; Kajta M; Smiałowska M
Pharmacol Rep; 2006; 58(6):846-58. PubMed ID: 17220542
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus.
Domin H; Zięba B; Gołembiowska K; Kowalska M; Dziubina A; Śmiałowska M
Pharmacol Rep; 2010; 62(6):1051-61. PubMed ID: 21273662
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
4. Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus.
Śmiałowska M; Gołembiowska K; Kajta M; Zięba B; Dziubina A; Domin H
Neurotox Res; 2012 May; 21(4):379-92. PubMed ID: 22144346
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
Domin H; Jantas D; Śmiałowska M
Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
[TBL] [Abstract][Full Text] [Related]
6. MTEP, a Selective mGluR5 Antagonist, Had a Neuroprotective Effect but Did Not Prevent the Development of Spontaneous Recurrent Seizures and Behavioral Comorbidities in the Rat Lithium-Pilocarpine Model of Epilepsy.
Dyomina AV; Kovalenko AA; Zakharova MV; Postnikova TY; Griflyuk AV; Smolensky IV; Antonova IV; Zaitsev AV
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008924
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo.
Smiałowska M; Domin H; Zieba B; Koźniewska E; Michalik R; Piotrowski P; Kajta M
Neuropeptides; 2009 Jun; 43(3):235-49. PubMed ID: 19318226
[TBL] [Abstract][Full Text] [Related]
8. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M
Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo.
Szydlowska K; Kaminska B; Baude A; Parsons CG; Danysz W
Eur J Pharmacol; 2007 Jan; 554(1):18-29. PubMed ID: 17109843
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures.
Xapelli S; Silva AP; Ferreira R; Malva JO
Peptides; 2007 Feb; 28(2):288-94. PubMed ID: 17212973
[TBL] [Abstract][Full Text] [Related]
11. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus.
Smiałowska M; Wierońska JM; Szewczyk B
Pol J Pharmacol; 2003; 55(6):979-86. PubMed ID: 14730092
[TBL] [Abstract][Full Text] [Related]
14. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro.
Kajta M; Makarewicz D; Ziemińska E; Jantas D; Domin H; Lasoń W; Kutner A; Łazarewicz JW
Neurochem Int; 2009 Sep; 55(5):265-74. PubMed ID: 19576513
[TBL] [Abstract][Full Text] [Related]
16. Effects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance.
Yang ST; Wang M; Galvin V; Yang Y; Arnsten AFT
Psychopharmacology (Berl); 2021 Jan; 238(1):97-106. PubMed ID: 32939596
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications.
Iso Y; Grajkowska E; Wroblewski JT; Davis J; Goeders NE; Johnson KM; Sanker S; Roth BL; Tueckmantel W; Kozikowski AP
J Med Chem; 2006 Feb; 49(3):1080-100. PubMed ID: 16451073
[TBL] [Abstract][Full Text] [Related]
18. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
Lea PM; Faden AI
CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of memantine against Doxorubicin toxicity in primary neuronal cell cultures: influence a development stage.
Jantas D; Lason W
Neurotox Res; 2009 Jan; 15(1):24-37. PubMed ID: 19384585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
